Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles

Biomaterials

Volumn 34, Issue 17, 2013, Pages 4339-4346

  Stano, Armando ^a   Scott, Evan A ^a   Dane, Karen Y ^a   Swartz, Melody A ^a   Hubbell, Jeffrey A ^a  

^a EPFL   (Switzerland)

Author keywords

Flow cytometry; Immune response; Immunomodulation; Immunostimulation; Nanoparticle

Indexed keywords

CYTOTOXIC T LYMPHOCYTES; DISULFIDE LINKS; EQUIVALENT DOSE; IMMUNE RESPONSE; IMMUNO MODULATIONS; IMMUNOSTIMULATION; POLY(PROPYLENE SULFIDE) (PPS); PROTEIN ANTIGENS;

ANTIGENS; CELLS; CYTOLOGY; FLOW CYTOMETRY; NANOPARTICLES; POLYETHYLENE GLYCOLS; PROPYLENE; T-CELLS;

IMMUNE SYSTEM;

ANTIGEN; DISULFIDE; MACROGOL; NANOCARRIER; NANOPARTICLE; OVALBUMIN; POLY(PROPYLENE SULFIDE); POLYMER; POLYMERSOME; SOLID CORE NANOPARTICLE; SULFIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONJUGATION; CPG ISLAND; FEMALE; IMMUNIZATION; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; CELL PROLIFERATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNITY; MICE; MICE, INBRED C57BL; NANOPARTICLES; OVALBUMIN; PHENOTYPE; POLYETHYLENE GLYCOLS; SPLEEN; SULFIDES; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

MUS;

EID: 84875553460     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.024     Document Type: Article

References (26)

1. Hansson M., Nygren P.A., Stahl S. Design and production of recombinant subunit vaccines. Biotechnol Appl Biochem 2000, 32:95-107.
2. Hubbell J.A., Thomas S.N., Swartz M.A. Materials engineering for immunomodulation. Nature 2009, 462:449-460.
3. Bramwell V.W., Perrie Y. Particulate delivery systems for vaccines: what can we expect?. J Pharm Pharmacol 2006, 58:717-728.
4. Chadwick S., Kriegel C., Amiji M. Nanotechnology solutions for mucosal immunization. Adv Drug Deliv Rev 2010, 62:394-407.
5. Rehor A., Hubbell J.A., Tirelli N. Oxidation-sensitive polymeric nanoparticles. Langmuir 2005, 21:411-417.
6. van der Vlies A.J., O'Neil C.P., Hasegawa U., Hammond N., Hubbell J.A. Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins. Bioconjug Chem 2010, 21:653-662.
7. Scott E.A., Stano A., Gillard M., Maio-Liu A.C., Swartz M.A., Hubbell J.A. Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes. Biomaterials 2012, 33:6211-6219.
8. Ballester M., Nembrini C., Dhar N., de Titta A., de Piano C., Pasquier M., et al. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine 2011, 29:6959-6966.
9. Hirosue S., Kourtis I.C., van der Vlies A.J., Hubbell J.A., Swartz M.A. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: cross-presentation and T cell activation. Vaccine 2010, 28:7897-7906.
10. Nembrini C., Stano A., Dane K.Y., Ballester M., van der Vlies A.J., Marsland B.J., et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A 2011, 108:989-997.
11. Reddy S.T., van der Vlies A.J., Simeoni E., Angeli V., Randolph G.J., O'Neil C.P., et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 2007, 25:1159-1164.
12. Stano A., van der Vlies A.J., Martino M.M., Swartz M.A., Hubbell J.A., Simeoni E. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine 2011, 29:804-812.
13. Discher D.E., Ahmed F. Polymersomes. Annu Rev Biomed Eng 2006, 8:323-341.
14. Lee J.S., Feijen J. Polymersomes for drug delivery: design, formation and characterization. J Control Release 2012, 161:473-483.
15. Massignani M., Lomas H., Battaglia G. Polymersomes: a synthetic biological approach to encapsulation and delivery. Adv Polym Sci 2010, 229:115-154.
16. Quer C.B., Marsden H.R., Romeijn S., Zope H., Kros A., Jiskoot W. Polymersomes enhance the immunogenicity of influenza subunit vaccine. Polym Chem UK 2011, 2:1482-1485.
17. Kamala T. Hock immunization: a humane alternative to mouse footpad injections. J Immunol Methods 2007, 328:204-214.
18. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37.
19. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
20. Suni M.A., Maino V.C., Maecker H.T. Ex vivo analysis of T-cell function. Curr Opin Immunol 2005, 17:434-440.
21. Belizaire R., Unanue E.R. Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A 2009, 106:17463-17468.
22. Joffre O.P., Segura E., Savina A., Amigorrena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012, 12:557-569.
23. Stano A., Nembrini C., Swartz M.A., Hubbell J.A., Simeon E. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization. Vaccine 2012, 30:7541-7546.
24. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005, 175:3463-3468.
25. Longhi M.P., Wright K., Lauder S.N., Nowell M.A., Jones G.W., Godkin A.J., et al. Interleukin-6 is crucial for recall of influenza-specific memory CD4(+) T cells. Plos Pathog 2008, 4.
26. Discher B.M., Won Y.Y., Ege D.S., Lee J.C.M., Bates F.S., Discher D.E., et al. Polymersomes: tough vesicles made from diblock copolymers. Science 1999, 284:1143-1146.